3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Myelodysplastic Syndromes
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Hematologic Neoplasms
3
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Graft vs Host Disease
2
Ganglioneuroblastoma
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Teratoma
1
Recurrence
1
Neuroblastoma
1
Multiple Myeloma
1
Medulloblastoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Mast-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia
1
High Risk Myeloid Malignancies
1
GATA2 Deficiency
1
Choriocarcinoma
1
Carcinoma, Embryonal
1
Interventions
X-Rays
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Nuclear Medicine Department, Hospital
5
Biopsy
4
tazemetostat
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Topotecan
2
Methotrexate
2
LY3023414
2
Etoposide
2
Cisplatin
2
Carboplatin
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Thiotepa
×
90 days
×
Clear all
No trials found.